To understand the role of A3B in tumor evolution and therapy resistance, several mouse strains incorporating a human A3B transgene were engineered to mimic clonal and subclonal induction of A3B in oncogene-driven NSCLC and human preclinical models and clinical specimens were studied. The gene discussed is APOBEC3B; the disease is neoplasm.